José Luis Piñana

1 month ago | nature.com | José Luis Piñana |Juan Montoro |Rafael Hernani |Pedro Chorão |Juan Carlos Hernandez-Boluda |David Navarro

Respiratory syncytial virus (RSV) poses a significant threat to allogeneic hematopoietic cell transplant (allo-HCT) recipients. Prolonged shedding in this population is common [1], increasing the risk of viral transmission and resistance [2], placing additional strain on healthcare systems. Despite the clinical importance of understanding illness duration in these patients, data remain limited [3].

Mar 20, 2024 | onlinelibrary.wiley.com | Estela Giménez |Roberto Gozalbo-Rovira |Eliseo Albert |José Luis Piñana

1 INTRODUCTION Monitoring of Cytomegalovirus (CMV) DNA in blood is a cornerstone in the management of CMV infection in the allogeneic hematopoietic stem cell transplant setting (allo-SCT) as it allows timely administration of anti-CMV drugs (preemptive antiviral therapy [PET]) to prevent the occurrence of CMV end-organ disease.1, 2 Commercially available Real-time PCR assays, either performed on whole blood or plasma, are recommended for CMV DNA quantification in the systemic compartment.3...

Mar 17, 2024 | mdpi.com | Eliseo Albert |Estela Giménez |Rafael Hernani |José Luis Piñana

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.